F. Lador (Geneva 14, Switzerland), I. Preston (Boston, United States of America), L. Howard (London, United Kingdom), R. Souza (Sao Paulo, Brazil)
Left heart dysfunction in COPD- Ignored combination
D. Singh, K. Agarwal, V. Joshi, G. Purohit, S. Patil (Jodhpur, India)
|   |
Systemic vascular function in chronic obstructive pulmonary disease
R. Del Pozo, J. Garcia, N. Chamorro, M. Coronel, N. Coll, I. Blanco, V. Peinado, J. A. Barberà (Barcelona, Spain)
| |
Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
C. Antonaglia, M. Jevnikar, E. Agastra, P. Geri, M. Confalonieri, M. Kodric, C. Longo (Trieste, Italy)
| |
Effect of omeprazole and AlOH/MgOH on riociguat absorption
C. Becker, R. Frey, S. Unger, U. Artmeier-Brandt, G. Weimann, W. Mueck (Wuppertal, Germany)
| |
Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension
M. Delcroix, G. Simonneau, E. Bergot, A. Boonstra, J. Granton, D. Langleben, P. Escribano Subias, N. Galiè, T. Pfister, J. C. Lemarié, O. Sitbon (Leuven, Belgium; Le Kremlin-Bicêtre, Caen, Paris, France; Amsterdam, Netherlands; Toronto, Montreal, Canada; Madrid, Spain; Bologna, Italy; Allschwil, Switzerland)
| |
Right ventricular dysfunction in pulmonary hypertension with combined pulmonary fibrosis and emphysema syndrome
A. Swift, S. Rajaram, D. Capener, C. Hill, C. Davies, J. Hurdman, R. Condliffe, C. Elliot, D. Kiely, J. Wild (Sheffield, United Kingdom)
| |
Correlation of ECG-gated 320-row multidetector computed tomography measurement of pulmonary arterial distensibility with hemodynamic factors in chronic thromboembolic pulmonary hypertension
H. Kasai, T. Sugiura, T. Nobuhiro, M. Yahaba, Y. Sakurai, A. Shigeta, N. Kawata, S. Sakao, Y. Kasahara, K. Tatsumi (Chiba, Japan)
| |
Retrospective observational study of pulmonary hypertension patients dosed with greater than 9 breaths qid of inhaled treprostinil
A. Poms, S. McNeilly, T. Fortin, V. F. Tapson (Durham, United States Of America)
| |
EPITOME-4, a phase 3b study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension following switch from Flolan®
Y. Tamura, T. Ono, K. Fukuda, T. Satoh, S. Sasayama (Tokyo, Kyoto, Japan)
| |
Pulmonary atherosclerosis observed by intravascular ultrasound
E. Belyatko, N. Danilov, M. Mitroshkin, Y. Matchin, T. Martynyuk, I. Chazova (Moscow, Russian Federation)
| |
Prognostic value of changes in radionuclide right ventricular ejection fraction in pulmonary arterial hypertension
V. Cottin, P. Y. Courand, C. Khouatra, G. Pina-Jomir, C. Scheiber, J. Traclet, J. C. Glerant, S. Turquier, M. Humbert, G. Simonneau, J. F. Mornex, J. F. Cordier (Lyon, Paris, France)
| |
Left atrial enlargement is not rare in PAH- RA/LA ratio is significantly lower in PH due to left heart disease
M. Held, M. Römmelt, G. Huebner, B. Jany (Wuerzburg, Germany)
| |
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function
A. A. Stanziola, G. Carlomagno, C. Vitale, M. Lanza, V. Mercurio, S. Fazio, M. Sofia (Naples, Italy)
| |
EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension
J. Yorke, I. Armstrong, C. Harries (Manchester, Sheffield, United Kingdom)
| |
The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians
E. Ibrahim, A. Kassem, N. Zakaria (Alexandria, Egypt)
| |
Predicting pulmonary hypertension with standard computed tomography angiography
O. Spruijt, F. de Man, R. Lelij, H. J. Bogaard, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Accuracy and precision of assessment of pulmonary vascular resistance
E. Lonsdorfer, I. Enache, M. Canuet, P. Di Marco, A. Charloux, S. Doutreleau (Strasbourg, France)
| |
Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables
F. Rischard, S. Knoper (Tucson, United States Of America)
| |
Accurate monitoring of the right ventricular ejection fraction by echocardiography in pulmonary hypertension
T. Sato, I. Tsujino, N. Oyama-Manabe, H. Ohira, T. Watanabe, M. Nishimura (Sapporo, Japan)
| |
About cardiac output assessment in pulmonary hypertension
I. Enache, M. Canuet, P. Di Marco, E. Lonsdorfer, M. Oswald, A. Charloux, S. Doutreleau (Strasbourg, France)
| |